These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20723158)

  • 1. Predictive factors associated with left ventricular hypertrophy at baseline and in the follow-up period in non-diabetic hemodialysis patients.
    Io H; Matsumoto M; Okumura K; Sato M; Masuda A; Furukawa M; Nohara N; Tanimoto M; Kodama F; Hagiwara S; Gohda T; Shimizu Y; Tomino Y
    Semin Dial; 2011; 24(3):349-54. PubMed ID: 20723158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for Prevention of Left Ventricular Remodeling in Predialysis and Dialysis Patients.
    Io H; Suzuki Y
    Contrib Nephrol; 2018; 196():13-21. PubMed ID: 30041199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.
    Matsumoto M; Io H; Furukawa M; Okumura K; Masuda A; Seto T; Takagi M; Sato M; Nagahama L; Omote K; Hisada A; Horikoshi S; Tomino Y
    J Nephrol; 2012; 25(5):794-801. PubMed ID: 22241636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
    Kim ED; Sozio SM; Estrella MM; Jaar BG; Shafi T; Meoni LA; Kao WH; Lima JA; Parekh RS
    BMC Nephrol; 2015 Aug; 16():131. PubMed ID: 26249016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors associated with change rates of LV hypertrophy and renal dysfunction in CKD patients.
    Okumura K; Io H; Matsumoto M; Seto T; Takagi M; Masuda A; Furukawa M; Nagahama L; Omote K; Hisada A; Hamada C; Horikoshi S; Tomino Y
    Clin Nephrol; 2013 Jan; 79(1):7-14. PubMed ID: 23036229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.
    Tian JP; Wang T; Wang H; Cheng LT; Tian XK; Lindholm B; Axelsson J; Du FH
    Ren Fail; 2008; 30(4):391-400. PubMed ID: 18569912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients.
    Moon KH; Song IS; Yang WS; Shin YT; Kim SB; Song JK; Park JS
    Am J Nephrol; 2000; 20(5):396-401. PubMed ID: 11092998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrophy in incident dialysis patients randomized to treatment with hemofiltration or hemodialysis: results from the ProFil study.
    Alvestrand A; Ledebo I; Hagerman I; Wingren K; Mattsson E; Qureshi AR; Gutierrez A
    Blood Purif; 2011; 32(1):21-9. PubMed ID: 21252503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum renalase in hemodialysis patients: is it related to left ventricular hypertrophy?
    Oguz EG; Gursoy GK; Yayar O; Yildirim T; Cimen T; Bulut C; Eser B; Canbakan B; Yeter E; Ayli MD
    Ren Fail; 2016 Sep; 38(8):1180-6. PubMed ID: 27416751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation.
    Covic A; Mardare NG; Ardeleanu S; Prisada O; Gusbeth-Tatomir P; Goldsmith DJ
    J Nephrol; 2006; 19(6):783-93. PubMed ID: 17173253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.
    Zoccali C; Benedetto FA; Mallamaci F; Tripepi G; Giacone G; Stancanelli B; Cataliotti A; Malatino LS
    Kidney Int; 2004 Apr; 65(4):1492-8. PubMed ID: 15086493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular mass index and aortic arch calcification score are independent mortality predictors of maintenance hemodialysis patients.
    Liu S; Zhang DL; Guo W; Cui WY; Liu WH
    Hemodial Int; 2012 Oct; 16(4):504-11. PubMed ID: 22520823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia.
    Thanakitcharu P; Siriwiwatanakul N
    J Med Assoc Thai; 2007 Dec; 90(12):2574-86. PubMed ID: 18386706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of left ventricular hypertrophy in patients with chronic kidney disease.
    Yilmaz BA; Mete T; Dincer I; Kutlay S; Sengül S; Keven K; Ertürk S
    Ren Fail; 2007; 29(3):303-7. PubMed ID: 17497444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late referral to a nephrologist increases the risk of uremia-related cardiac hypertrophy in patients on hemodialysis.
    Shin SJ; Kim HW; Chung S; Chung HW; Lee SJ; Kim YS; Bang BK; Chang YS; Park CW
    Nephron Clin Pract; 2007; 107(4):c139-46. PubMed ID: 17957125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mitofilin in left ventricular hypertrophy in hemodialysis patients.
    Wu QS; He Q; He JQ; Chao J; Wang WY; Zhou Y; Lou JZ; Kong W; Chen JF
    Ren Fail; 2018 Nov; 40(1):252-258. PubMed ID: 29619900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of anemia and hypertension to left ventricular hypertrophy during the initial 2 years after renal transplantation.
    Ibernon M; Moreso F; Ruiz-Majoral A; Sarrias X; Sarrias M; Grinyó JM; Serón D
    Transplant Proc; 2011; 43(6):2199-204. PubMed ID: 21839233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of left ventricular hypertrophy in hemodialysis patients is possible.
    Hampl H; Sternberg C; Berweck S; Lange D; Lorenz F; Pohle C; Riedel E; Gogoll L; Hennig L
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S73-96. PubMed ID: 12227731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.